Evidence map›Paper›PMID 23843611›Full record

ArticleJournal of cell science2013

14-3-3 protein targets misfolded chaperone-associated proteins to aggresomes.

Zhe Xu, Kourtney Graham, Molly Foote, Fengshan Liang, Raed Rizkallah, Myra Hurt, Yanchang Wang, Yuying Wu, Yi Zhou

Abstract read
In one paragraph

Article in Journal of cell science, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 62 papers.

0numbers the graph read from it
0cells of the map it votes in
62citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

62 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. MARK2 phosphorylates KIF13A at a 14-3-3 binding site to polarize vesicular transport of transferrin receptor within dendrites.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. The role of BAG3 in dilated cardiomyopathy and its association with Charcot-Marie-Tooth disease type 2.Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology · 2022
    Review
  15. Article
  16. Review
  17. Valosin Containing Protein (VCP): A Multistep Regulator of Autophagy.International journal of molecular sciences · 2022
    Review
  18. Review
  19. Review
  20. Article

2 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Zhe XuDepartment of Biomedical Sciences, Florida State University College of Medicine, Tallahassee, FL 32306, USA.
Kourtney Graham
Molly Foote
Fengshan Liang
Raed Rizkallah
Myra Hurt
Yanchang Wang
Yuying Wu
Yi Zhou

Funding

Functions of the N-type Ca Channel/14-3-3 InteractionR01NS050355 · NINDS · FLORIDA STATE UNIVERSITY · PI ZHOU, YI · 2007 to 2011
$1.4M
Investigate the Molecular Basis that Controls the Timing of Spindle ElongationR15GM097326 · NIGMS · FLORIDA STATE UNIVERSITY · PI WANG, YANCHANG · 2011 to 2011
$281k
NIGMS NIH HHS R15 GM097326NINDS NIH HHS NS50355NINDS NIH HHS R01 NS050355
6 · The paper itself

Abstract

The aggresome is a key cytoplasmic organelle for sequestration and clearance of toxic protein aggregates. Although loading misfolded proteins cargos to dynein motors has been recognized as an important step in the aggresome formation process, the molecular machinery that mediates the association of cargos with the dynein motor is poorly understood. Here, we report a new aggresome-targeting pathway that involves isoforms of 14-3-3, a family of conserved regulatory proteins. 14-3-3 interacts with both the dynein-intermediate chain (DIC) and an Hsp70 co-chaperone Bcl-2-associated athanogene 3 (BAG3), thereby recruiting chaperone-associated protein cargos to dynein motors for their transport to aggresomes. This molecular cascade entails functional dimerization of 14-3-3, which we show to be crucial for the formation of aggresomes in both yeast and mammalian cells. These results suggest that 14-3-3 functions as a molecular adaptor to promote aggresomal targeting of misfolded protein aggregates and may link such complexes to inclusion bodies observed in various neurodegenerative diseases.

Indexed as

14-3-3 ProteinsDyneinsMolecular ChaperonesProtein FoldingProteinsTransfection14-3-3 ProteinsDyneinsMolecular ChaperonesProteins14-3-3AdaptorAggresomeBAG3Dynein

Identifiers

PMID23843611
PMCPMC3772389

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.